Skip to main content
Have a personal or library account? Click to login
Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2 Cover

Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2

Interdisciplinary Toxicology
Volume 1 (2008): Issue 2 (September 2008)
By: ,  ,  ,  ,  ,   and    
Open Access
|Nov 2010
References

References

  1. Aimová D, Svobodová L, Kotrbová V, Mrázová B, Hodek P, Hudecek J, Václavíková R, Frei E, Stiborová M (2007) The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.: 1926-34.
    Open DOISearch in Google Scholar
  2. Arlt VM, Henderson CJ, Wolf CR, Schmeiser HH, Phillips DH, Stiborova M (2006) Bioactivation of 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone: evidence for DNA adduct formation mediated by cytochrome P450 enzymes and peroxidases.: 220-31.
    Open DOISearch in Google Scholar
  3. Arlt VM, Hewer A, Sorg BL, Schmeiser HH, Phillips DH, Stiborova M (2004) 3-Aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.: 1092-101.
    Open DOISearch in Google Scholar
  4. Arlt VM, Stiborova M, Henderson CJ, Osborne MR, Bieler CA, Frei E, Martinek V, Sopko B, Wolf CR, Schmeiser HH, Phillips DH (2005) Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H: quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols.: 2644-52.
    Open DOISearch in Google Scholar
  5. Arlt VM, Stiborová M, Henderson CJ, Thiemann M, Frei E, Aimová D, Singh R, Gamboa da Costa G, Schmitz OJ, Farmer PB, Wolf CR, Phillips DH (2008) Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.: 656-65.
    Search in Google Scholar
  6. Arlt VM, Stiborova M, Hewer A, Schmeiser HH, Phillips DH (2003) Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH: cytochrome P450 reductase.: 2752-61.
    Search in Google Scholar
  7. Baird WM, Hooven LA, Mahadevan B (2005) Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action.: 106-14.
    Open DOISearch in Google Scholar
  8. Bořek-Dohalská L, Frei E, Stiborová M (2004) DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells.: 603-615.
    Open DOISearch in Google Scholar
  9. Frei E, Bieler CA, Arlt VM, Wiessler M, Stiborová M (2002) Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes.: 289-95.
    Open DOISearch in Google Scholar
  10. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.: 13480-6.
    Open DOISearch in Google Scholar
  11. Henderson CJ, Pass GJ, Wolf CR (2006) The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity.: 111-7.
    Open DOISearch in Google Scholar
  12. IARC Monogr Eval Carcinog Risk Chem Hum (1983) Polynuclear Aromatic Compounds, 211.
    Search in Google Scholar
  13. Kotrbová V, Aimová D, Březinová A, Janouchová K, Poljaková J, Hodek P, Frei E, Stiborová M (2006) Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.(Suppl. 2): 18-20.
    Search in Google Scholar
  14. Kouri RE, Salerno RA, Whitmire CE (1973) Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice.: 363-8.
    Open DOISearch in Google Scholar
  15. Phillips DH (1999) Polycyclic aromatic hydrocarbons in the diet.: 139-47.
    Open DOISearch in Google Scholar
  16. Phillips DH (2002) Smoking-related DNA and protein adducts in human tissues: 1979-2004.
    Open DOISearch in Google Scholar
  17. Poljaková J, Dračínský M, Frei E, Hudeček J Stiborová, M (2006) The effect ofon peroxidase-mediated oxidation of and DNA-adduct formation by ellipticine.: 1169-1185.
    Open DOISearch in Google Scholar
  18. Poljaková J, Frei E, Gomez JE, Aimová D, Eckschlager T, Hraběta J, Stiborová M (2007) DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells.: 270-9.
    Open DOISearch in Google Scholar
  19. Stiborová M, Arlt VM, Henderson CJ, Wolf CR, Kotrbová V, Moserová M, Hudecek J, Phillips DH, Frei E. (2008) Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH: cytochrome P450 reductase null mouse.: 318-27.
    Open DOISearch in Google Scholar
  20. Stiborová M, Bieler CA, Wiessler M, Frei E (2001) The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.: 675-84.
    Open DOISearch in Google Scholar
  21. Stiborová M, Bořek-Dohalská L, Aimová D, Kotrbová V, Kukačková K, Janouchová K, Rupertová M, Ryšlavá H, Hudeček J, Frei E (2006a) Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - Similarity between human and rat systems.: 245-261.
    Search in Google Scholar
  22. Stiborová M, Breuer A, Aimová D, Stiborová-Rupertová M, Wiessler M, Frei E (2003a) DNA adduct formation by the anticancer drug ellipticine in rats determined byP-postlabeling.: 885-890.
    Open DOISearch in Google Scholar
  23. Stiborová M, Martínek V, Rýdlová H, Koblas T, Hodek P (2005) Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers.: 145-154.
    Open DOISearch in Google Scholar
  24. Stiborová M, Poljaková J, Ryšlavá H, Dračínský M, Eckschlager T, Frei E (2007a) Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those foundand generated from 12-hydroxyellipticine and 13-hydroxyellipticine.: 243-251.
    Open DOISearch in Google Scholar
  25. Stiborová M, Rupertová M, Aimová D, Ryšlavá H, Frei E (2007b) Formation and persistence of DNA adducts of anticancer drug ellipticine in rats.: 50-60.
    Open DOISearch in Google Scholar
  26. Stiborová M, Rupertová M, Schmeiser HH, Frei E (2006b) Molecular mechanism of antineoplastic action of an anticancer drug ellipticine.: 13-23.
    Open DOISearch in Google Scholar
  27. Stiborová M, Sejbal J, Bořek-Dohalská L, Aimová D, Poljaková J, Forsterová K, Rupertová M, Wiesner J, Hudeček J, Wiessler M, Frei E (2004) The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine-oxide.: 8374-8380.
    Open DOISearch in Google Scholar
  28. Stiborová M, Stiborová-Rupertová M, Bořek-Dohalská L, Wiessler M, Frei E (2003b) Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.: 38-47.
    Open DOISearch in Google Scholar
  29. Svobodová M Šístková J, Dračínská H, Hudeček J, Hodek P, Schmeiser HH, Arlt VM, Frei E, Stiborová M (2007) Reductive activation of environmental pollutants 3-nitrobenzanthrone and 2-nitrobenzanthrone.: s277-s279.
    Search in Google Scholar
  30. Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, Nebert DW (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.: 1225-37.
    Open DOISearch in Google Scholar
  31. Uno S, Dalton TP, Dragin N, Curran CP, Derkenne S, Miller ML, Shertzer HG, Gonzalez FJ, Nebert DW (2006) Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.: 1103-14.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10102-010-0033-z | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Journal RSS Feed
Language: English
Page range: 160 - 168
Published on: Nov 1, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
benzo(a)pyrene,
ellipticine,
induction,
cytochromes P450,
NADPH:cytochrome P450 reductase,
HRN™,
mice
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2010 Dagmar Aimová, Jitka Poljaková, Věra Kotrbová, Michaela Moserová, Eva Frei, Volker Arlt, Marie Stiborová, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.

Volume 1 (2008): Issue 2 (September 2008)
Previous article
Next article